Co-Authors
This is a "connection" page, showing publications co-authored by SANJEEV VASUDEVAN and ANDRAS HECZEY.
Connection Strength
1.273
-
A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 Apr; 80(4):610-621.
Score: 0.235
-
Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy. Cancer Med. 2023 12; 12(23):21270-21278.
Score: 0.232
-
Surgical Management and Outcomes of Patients with Multifocal Hepatoblastoma. J Pediatr Surg. 2023 Sep; 58(9):1715-1726.
Score: 0.224
-
Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction. J Pediatr Surg. 2022 Aug; 57(8):1544-1553.
Score: 0.198
-
Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg. 2017 Jun; 52(6):956-961.
Score: 0.146
-
The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience. Pediatr Blood Cancer. 2024 Nov; 71(11):e31214.
Score: 0.061
-
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022 10; 77(4):1026-1037.
Score: 0.052
-
Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma. J Pediatr Hematol Oncol. 2021 Nov 01; 43(8):e1181-e1185.
Score: 0.050
-
Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. Pediatr Blood Cancer. 2019 07; 66(7):e27745.
Score: 0.042
-
Undifferentiated Embryonal Sarcoma of the Liver (UESL): A Single-Center Experience and Review of the Literature. J Pediatr Hematol Oncol. 2016 05; 38(4):261-8.
Score: 0.034